DEFINITION of vitreous

The vitreous (also called the vitreous body, vitreous humor, or corpus vitreum) is a transparent, gelatinous substance that fills the posterior segment of the eyeball — the space between the crystalline lens anteriorly and the retina posteriorly. It comprises approximately 80% of the eye’s total volume and is composed primarily of water (~99%), along with hyaluronic acid, collagen fibrils (type II), and scattered hyalocytes (phagocytic cells). The vitreous serves to maintain the spherical shape of the eye, support the retina against the posterior wall, and allow undistorted transmission of light to the macula. Unlike aqueous humor, vitreous is not continuously replenished — it is largely acellular and avascular. With aging, the gel undergoes liquefaction (synchysis) and collapse (syneresis), often leading to posterior vitreous detachment (PVD), floaters, or, in complicated cases, traction on the retina. During vitrectomy, the vitreous is replaced with saline, gas bubbles, or silicone oil.


ETYMOLOGY of vitreous

latin From Latin vitreus (“of glass,” “glassy”), derived from vitrum (“glass”). The adjective describes the substance’s hallmark transparency and glass-like clarity, as observed by early anatomists during dissection. The companion word humor (Latin: umor, “fluid, moisture”) reflects the historical four-humors theory of medicine. Together, vitreous humor = “glassy fluid.” The adjective form vitreous was first used in English in the 14th century; the noun form referring to the eye structure dates to 1869 (Merriam-Webster). The prefix vitre-/vitro- appears in related terms such as vitreoretinal and vitritis.


ALIASES / RELATED TERMS to vitreous

TermMeaning
Vitreous body (corpus vitreum)Full anatomical name
Vitreous humorCommon clinical name
Hyaloid bodyOlder/alternate term (from Greek hyalos = glass)
VitrectomySurgical removal of the vitreous
IntravitrealWithin the vitreous (route of injection)
Posterior vitreous detachment (PVD)Separation of vitreous from retina
Vitreous floatersDebris/opacities within the vitreous
SynchysisLiquefaction of vitreous gel
SyneresisCollapse/shrinkage of the vitreous gel framework
VitritisInflammation within the vitreous (coded H43.89)
Hyaloid membraneOuter membrane enclosing the vitreous
Retinal detachmentCommon complication of vitreous traction/PVD

CODING CONTEXT

ICD-10-CM

(Vitreous Disorders, Category H43)

Vitreous Prolapse

ICD-10Description
H43.00Vitreous prolapse, unspecified eye
H43.01Vitreous prolapse, right eye
H43.02Vitreous prolapse, left eye
H43.03Vitreous prolapse, bilateral

Vitreous Hemorrhage

ICD-10Description
H43.10Vitreous hemorrhage, unspecified eye
H43.11Vitreous hemorrhage, right eye
H43.12Vitreous hemorrhage, left eye
H43.13Vitreous hemorrhage, bilateral

Crystalline Deposits / Opacities (Floaters)

ICD-10Description
H43.391Other vitreous opacities, right eye
H43.392Other vitreous opacities, left eye
H43.393Other vitreous opacities, bilateral
H43.399Other vitreous opacities, unspecified eye

Vitreous Degeneration / Detachment (PVD)

ICD-10Description
H43.811Vitreous degeneration, right eye
H43.812Vitreous degeneration, left eye
H43.813Vitreous degeneration, bilateral
H43.819Vitreous degeneration, unspecified eye

Vitreous Membranes and Strands

ICD-10Description
H43.311Vitreous membranes and strands, right eye
H43.312Vitreous membranes and strands, left eye
H43.313Vitreous membranes and strands, bilateral
H43.319Vitreous membranes and strands, unspecified eye

Other / Unspecified

ICD-10Description
H43.89Other disorders of vitreous body (includes vitritis)
H43.9Unspecified disorder of vitreous body

CPT (Vitreous Procedures)

CPTDescription
67005Removal of vitreous, anterior approach (open-sky technique or limbal incision)
67010Removal of vitreous, anterior approach; subtotal removal, pars plana approach
67015Aspiration or release of vitreous, subretinal or choroidal fluid, pars plana approach
67025Injection of vitreous substitute, pars plana or limbal approach; fluid-gas exchange, with or without aspiration (separate procedure)
67027Implantation of intravitreal drug delivery system (e.g., ganciclovir implant), with or without removal of vitreous
67028Intravitreal injection of a pharmacologic agent (separate procedure)
67036Vitrectomy, mechanical, pars plana approach
67039Vitrectomy, mechanical, pars plana approach; with focal endolaser photocoagulation
67040Vitrectomy, mechanical, pars plana approach; with endolaser panretinal photocoagulation
67041Vitrectomy, mechanical, pars plana; with removal of preretinal cellular membrane (e.g., macular pucker)
67042Vitrectomy, mechanical, pars plana; with removal of internal limiting membrane of retina
67043Vitrectomy, mechanical, pars plana; with removal of subretinal membrane (e.g., AMD)

Key Coding Tips

  • 67025 (vitreous substitute) is a major surgery with a 90-day global period; 67028 (pharmacologic agent) is a minor procedure with zero global days.
  • 67015 is bundled with 67028 per NCCI edits — do not report together for the same eye; report 67015 alone (higher RVU).
  • For intravitreal injections, laterality modifiers are critical: -RT (right eye), -LT (left eye), -50 (bilateral — payer-dependent).
  • Additional modifiers: -59 or -XE to distinguish separately payable procedures; -78 for return to OR during global; -79 for unrelated procedure during global; -JW for discarded drug waste.
  • For bilateral vitrectomy, confirm payer rules — some require two separate line items with -RT/-LT rather than modifier -50.



Med roots | Appendix B Combining Forms | Appendix C Suffixes